Podcasts

Dr. Patricia Musolino of Mass General Brigham is pioneering gene editing approaches to treat Multisystem Smooth Muscle Dysfunction Syndrome (MSMDS)—a rare but devastating condition that causes stroke, heart attacks, and severe disability in childre...

What if we could prevent up to 40% of dementia cases, 60% of strokes, and 35% of depression—before they even start? In this episode, Dr. Jonathan Rosand, a neurologist and co-founder of the McCance Center for Brain Health at Mass General Brigham, j...

Clinical trial reporting is the bedrock of evidence-based oncology, yet it’s riddled with inefficiencies, mismatched data, and underreported adverse events. In this episode, Dr. Danielle Bitterman of Mass General Brigham joins unNatural Select...

Bernd Montag has led Siemens Healthineers through a decade of extraordinary transformation—spanning digitalization, AI, the Varian acquisition, and a global pandemic. Now, with its “New Ambition” strategy in motion, the company is positioning i...

Robert Langer is not just a scientist — he is one of the greatest scientific minds in human history. As the most cited engineer of all time and one of the ten most cited scientists across all fields, his work has shaped the modern landscape of biot...

What if you could regenerate the gut’s nervous system with a simple cell therapy? In this episode of unNatural Selection, Dr. Allan Goldstein—Surgeon-in-Chief at Mass General for Children and Chief of Pediatric Surgery at Massachusetts General Ho...

In this episode of unNatural Selection, produced in partnership with Mass General Brigham ahead of the World Medical Innovation Forum, we sit down with Dr. Andy Beck, CEO of PathAI, to explore how machine learning is transforming the world of patholo...

AI is entering the exam room—not to diagnose, but to listen. In this episode, we explore how ambient AI is transforming clinical documentation, freeing doctors from keyboards and returning their focus to patients. Shiv Rao, CEO of Abridge, joins us...